GAF Healthcare
Specialty Overview

Best Hospitals for Ovarian Cancer Treatment in Chennai, India

8 radiation oncology hospitals in our India network are listed in Chennai, accredited by JCI, NABH, NABL, with 4,035 beds combined.

8
Hospitals Listed
1
City
4.5
Avg. Rating
3
Accreditation Types
The Short Answer

This page lists the radiation oncology hospitals in our directory offering Ovarian Cancer Treatment in Chennai, India, including Apollo Hospitals, Greams Road, Gleneagles Global Hospital, Dr. Rela Institute and Medical Centre, SIMS Hospital and others. Each listing links through to the hospital's full profile page.

Including:🇮🇳 Apollo Hospitals, Greams Road🇮🇳 Gleneagles Global Hospital🇮🇳 Dr. Rela Institute and Medical Centre

Ask us about ovarian cancer treatment in Chennai, India

Share a few details and our care coordination team will get back to you with next steps.

Compare 8 accredited hospitals for Radiation Oncology in Chennai, India

Apollo Hospitals, Greams Road Featured
Starting from$1,000

🇮🇳 Apollo Hospitals, Greams Road

Chennai, India 4.7 (125 reviews) 560 beds
Why consider this hospital?
4.7/5 rating from 125 reviewsAccredited by JCI, NABH560 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by JCI, NABH

Patients considering ovarian cancer treatment can be cared for by Apollo Hospitals, Greams Road's care team in Chennai, India, from initial consultation through recovery. Apollo Hospitals, Greams Road, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing ovarian cancer treatment.

4.7/5
Rating
1983
Established
560
Beds
Chennai, India
Location
Enquire NowView Profile
Gleneagles Global Hospital
Starting from$1,000

🇮🇳 Gleneagles Global Hospital

Chennai, India 4.7 (112 reviews) 1,000 beds
Why consider this hospital?
4.7/5 rating from 112 reviewsAccredited by NABH, JCI1,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by NABH, JCI

Patients considering ovarian cancer treatment can be cared for by Gleneagles Global Hospital's care team in Chennai, India, from initial consultation through recovery. Gleneagles Global Hospital, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing ovarian cancer treatment.

4.7/5
Rating
1999
Established
1,000
Beds
Chennai, India
Location
Enquire NowView Profile
Dr. Rela Institute and Medical Centre
Starting from$1,000

🇮🇳 Dr. Rela Institute and Medical Centre

Chennai, India 4.7 (108 reviews) 450 beds
Why consider this hospital?
4.7/5 rating from 108 reviewsAccredited by NABH, NABL450 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by NABH, NABL

Patients considering ovarian cancer treatment can be cared for by Dr. Rela Institute and Medical Centre's care team in Chennai, India, from initial consultation through recovery. Dr. Rela Institute and Medical Centre, accredited by NABH, NABL, follows recognised patient-safety and quality-of-care standards when performing ovarian cancer treatment.

4.7/5
Rating
2018
Established
450
Beds
Chennai, India
Location
Enquire NowView Profile
SIMS Hospital
Starting from$1,000

🇮🇳 SIMS Hospital

Chennai, India 4.6 (20 reviews) 345 beds
Why consider this hospital?
4.6/5 rating from 20 reviewsAccredited by NABH, JCI345 beds
Specialties & Accreditation
Cardiac SurgeryNeurosciencesTransplantOrthopedicsGastroenterology
Accredited by NABH, JCI

Patients considering ovarian cancer treatment can be cared for by SIMS Hospital's care team in Chennai, India, from initial consultation through recovery. SIMS Hospital, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing ovarian cancer treatment.

4.6/5
Rating
1970
Established
345
Beds
Chennai, India
Location
Enquire NowView Profile
Sankara Nethralaya
Starting from$1,000

🇮🇳 Sankara Nethralaya

Nungambakkam, Chennai, India 4.4 (220 reviews) 200 beds
Why consider this hospital?
4.4/5 rating from 220 reviewsAccredited by NABH, NABL200 beds
Specialties & Accreditation
OphthalmologyRetina SurgeryCornea TransplantGlaucomaPediatric Ophthalmology
Accredited by NABH, NABL

Patients considering ovarian cancer treatment can be cared for by Sankara Nethralaya's care team in Nungambakkam, Chennai, India, from initial consultation through recovery. Sankara Nethralaya, accredited by NABH, NABL, follows recognised patient-safety and quality-of-care standards when performing ovarian cancer treatment.

4.4/5
Rating
1978
Established
200
Beds
Nungambakkam, Chennai, India
Location
Enquire NowView Profile
Apollo First Med Hospitals, Kilpauk
Starting from$1,000

🇮🇳 Apollo First Med Hospitals, Kilpauk

Kilpauk, Chennai, India 4.4 (76 reviews) 80 beds
Why consider this hospital?
4.4/5 rating from 76 reviewsAccredited by NABH, JCI80 beds
Specialties & Accreditation
Cardiac SciencesOrthopedicsNeurologyOncologyGastroenterology
Accredited by NABH, JCI

Patients considering ovarian cancer treatment can be cared for by Apollo First Med Hospitals, Kilpauk's care team in Kilpauk, Chennai, India, from initial consultation through recovery. Apollo First Med Hospitals, Kilpauk, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing ovarian cancer treatment.

4.4/5
Rating
2002
Established
80
Beds
Kilpauk, Chennai, India
Location
Enquire NowView Profile
MIOT International
Starting from$1,000

🇮🇳 MIOT International

Manapakkam, Chennai, India 4.4 (200 reviews) 1,000 beds
Why consider this hospital?
4.4/5 rating from 200 reviewsAccredited by NABH, NABL, JCI1,000 beds
Specialties & Accreditation
OrthopedicsCardiac SurgeryNeurosciencesTransplantOncology
Accredited by NABH, NABL, JCI

Patients considering ovarian cancer treatment can be cared for by MIOT International's care team in Manapakkam, Chennai, India, from initial consultation through recovery. MIOT International, accredited by NABH, NABL, JCI, follows recognised patient-safety and quality-of-care standards when performing ovarian cancer treatment.

4.4/5
Rating
1999
Established
1,000
Beds
Manapakkam, Chennai, India
Location
Enquire NowView Profile
MGM Healthcare
Starting from$1,000

🇮🇳 MGM Healthcare

Chennai, India 3.7 (34 reviews) 400 beds
Why consider this hospital?
3.7/5 rating from 34 reviewsAccredited by NABH, JCI400 beds
Specialties & Accreditation
Cardiac SurgeryNeurosciencesTransplantCancer CareOrthopedics
Accredited by NABH, JCI

Patients considering ovarian cancer treatment can be cared for by MGM Healthcare's care team in Chennai, India, from initial consultation through recovery. MGM Healthcare, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing ovarian cancer treatment.

3.7/5
Rating
1970
Established
400
Beds
Chennai, India
Location
Enquire NowView Profile
Our Methodology

How we selected these hospitals

A hospital appears on this page when Radiation Oncology is among its listed specialties and it is located in Chennai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for Ovarian Cancer Treatment in Chennai, India?

Choosing the right hospital for ovarian cancer treatment is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include radiation oncology rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding Ovarian Cancer Treatment

Ovarian cancer treatment encompasses a multimodal spectrum of interventions—including cytoreductive surgery, platinum-based chemotherapy, targeted biological agents (PARP inhibitors, bevacizumab), and HIPEC (Hyperthermic Intraperitoneal Chemotherapy)—delivering 5-year survival rates of 70–90% for early-stage disease and 30–40% for advanced stages when managed at high-volume oncology centres.

7–14 days (varies by stage: primary debulking surgery typically 7–10 days; HIPEC procedures 10–14 days; chemotherapy cycles are outpatient or short-stay)
Hospital Stay
4–8 weeks post-surgery for international flight clearance (longer end for HIPEC or interval debulking after neoadjuvant chemotherapy; chemotherapy-only patients may fly between cycles with oncologist approval)
Total Stay in Country (Fit-to-Fly)
70–90% (Stage I–II); 30–45% (Stage III–IV) — 5-year overall survival at high-volume centres
Success Rate

Clinical Overview

  • Ovarian cancer is the most lethal gynaecological malignancy, primarily because over 70% of cases are diagnosed at FIGO Stage III or IV, when the disease has disseminated beyond the pelvis into the peritoneal cavity and, less commonly, to distant organs.
  • The three principal histological subtypes are epithelial ovarian carcinoma (accounting for ~90% of cases, with high-grade serous carcinoma being the most common and aggressive variant), germ cell tumours (more common in younger women, with generally better prognosis), and sex cord-stromal tumours.
  • The disease causes progressive abdominal distension, ascites, bowel dysfunction, and systemic cachexia by compressing and infiltrating pelvic and abdominal structures; BRCA1/BRCA2 germline mutations confer a lifetime risk of 40–60% and are pivotal in treatment planning.
Full details →

Who is a Candidate?

  • ELIGIBLE PATIENTS:
  • Women with confirmed epithelial ovarian, fallopian tube, or primary peritoneal carcinoma at any FIGO stage seeking curative or optimal cytoreductive surgery
  • Patients with germ cell or sex cord-stromal ovarian tumours requiring fertility-sparing or radical surgery
  • Patients with BRCA1/BRCA2 mutations or HRD-positive tumours who are candidates for PARP inhibitor maintenance therapy
  • +21 more

Treatment Options & Approaches

  • SURGICAL APPROACHES:

Recovery

  • PHASE 1 — REMOTE PRE-CONSULTATION (Week 1–2, from home country):

Risks to be aware of

  • Ovarian cancer treatment carries a spectrum of surgical and oncological risks that patients must discuss candidly with their treating team.
  • Cytoreductive surgery — particularly when extended to include bowel resection, diaphragm stripping, or splenectomy — carries risks of intraoperative haemorrhage (transfusion rates 20–40% in radical procedures), anastomotic leak (2–5% for bowel resections), ileus (15–20%), wound infection or dehiscence (5–10%), and thromboembolic events (DVT/PE, 5–15% without prophylaxis).
Full details →

Why GAF Healthcare

  • GAF Healthcare provides comprehensive non-medical coordination so that patients and their families can focus entirely on treatment and recovery.

Cost Range for Related Procedures

Cancer Surgery$4,000–$15,000
Chemotherapy$1,000–$4,000
Radiation Therapy$3,500–$10,000
Get a personalised estimate with our cost calculator →

Common questions about Ovarian Cancer Treatment

What is the cost of Ovarian Cancer Treatment in India compared to the UAE?
The total cost of ovarian cancer treatment — covering primary cytoreductive surgery, 6–8 days of hospitalisation, standard medications, and 6 cycles of adjuvant carboplatin/paclitaxel chemotherapy — ranges from approximately $8,000 to $22,000 USD in India, depending on the stage of disease, extent of surgery (standard debulking vs. HIPEC), and the specific institution. In the UAE (Dubai or Abu Dhabi), equivalent treatment ranges from $18,000 to $45,000 USD, reflecting the higher infrastructure and operational costs of GCC healthcare. HIPEC (Hyperthermic Intraperitoneal Chemotherapy), when indicated, adds roughly $4,000–$6,000 in India and $10,000–$15,000 in the UAE. PARP inhibitor maintenance therapy (olaparib, niraparib) — prescribed for BRCA-mutated or HRD-positive patients after completing chemotherapy — costs an additional $1,500–$3,000 per month and is not typically included in surgical package pricing. India therefore offers savings of 40–65% compared to the UAE, while both destinations offer JCI-accredited centres, robotic surgery platforms, and molecular diagnostic services. GAF Healthcare provides a personalised, itemised cost estimate based on the patient's specific staging workup before any commitment is made.
How long do I need to stay in the country before I am fit to fly home after Ovarian Cancer Treatment?
The minimum safe in-country stay before international flight clearance depends primarily on the treatment modality. For patients undergoing open primary cytoreductive surgery (the most common approach for advanced-stage disease), the fit-to-fly milestone is typically 5–6 weeks post-surgery. This accounts for full wound healing, return of bowel function, haemodynamic stability, resolution of any post-operative complications (pleural effusion, anaemia), and the administration of the first cycle of adjuvant chemotherapy — which oncologists prefer to complete locally to monitor for initial toxicity. Patients who undergo robotic-assisted minimally invasive surgery (typically for early-stage or interval debulking) can generally achieve fit-to-fly status in 3–4 weeks. Patients receiving chemotherapy only (without surgery, e.g. neoadjuvant NACT prior to interval surgery, or palliative-intent treatment) may fly home between cycles — approximately 72–96 hours after infusion — with written clearance from their oncologist, as long as blood counts are adequate. HIPEC patients require an extended stay of 6–8 weeks due to the additional haematological and renal monitoring required. All patients flying after major abdominal surgery are provided with a written fit-to-fly letter, deep vein thrombosis prophylaxis (compression stockings and low-molecular-weight heparin for 10–14 days), and a comprehensive clinical handover package for their home-country oncologist. GAF Healthcare confirms fit-to-fly clearance formally before booking the patient's return flight.
What is the success rate of Ovarian Cancer Treatment at GAF Healthcare partner hospitals in India and the UAE?
Success rates for ovarian cancer are measured by 5-year overall survival and are directly determined by FIGO stage at diagnosis and the quality of initial surgical cytoreduction — specifically whether R0 resection (no macroscopic residual tumour) is achieved. At GAF Healthcare's partner institutions — including Tata Memorial Hospital (Mumbai), Apollo Cancer Centres, Manipal Hospitals (India) and Cleveland Clinic Abu Dhabi, Mediclinic City Hospital, and American Hospital Dubai (UAE) — published and institutional outcomes are as follows: Stage I: 85–93% 5-year survival; Stage II: 70–80%; Stage III with R0 resection: 40–50%; Stage III with residual disease >1 cm: 20–30%; Stage IV: 20–30% with optimal cytoreduction and bevacizumab/PARP inhibitor maintenance. The incorporation of PARP inhibitor maintenance (olaparib) in BRCA-mutated patients has dramatically improved progression-free survival — the SOLO-1 trial demonstrated that at 5 years, 48% of BRCA-mutated patients on olaparib maintenance had not experienced disease progression versus only 21% on placebo. Chemotherapy response rates to first-line carboplatin/paclitaxel reach 70–80% (objective response), though platinum resistance develops in the majority of advanced-stage patients within 2 years. It is important to understand that success in ovarian cancer management is increasingly defined not by cure alone, but by sustained quality of life, prolonged progression-free survival, and the ability to sequence effective therapies at recurrence — an approach that requires the level of multidisciplinary expertise and molecular diagnostics available at GAF Healthcare's partner centres.

Related pages

How GAF Healthcare Assists in Choosing the Best Hospital for Ovarian Cancer Treatment in Chennai, India

Discover the Top Hospitals for Ovarian Cancer Treatment in Chennai, India

This page lists 8 accredited radiation oncology hospitals in Chennai, India, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Common Questions

Frequently asked questions about ovarian cancer treatment in Chennai, India

How many radiation oncology hospitals are listed in Chennai, India?
8 hospitals in our Chennai, India directory are currently listed for radiation oncology including Ovarian Cancer Treatment.
How do you choose which hospitals to list?
A hospital appears on this page when Radiation Oncology is among its listed specialties and it is located in Chennai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in India?
Cost varies by hospital, city and individual case. Use our cost calculator for a personalized estimate — see the link on this page.
Are there radiation oncology hospitals for this in other India cities?
See the "Hospitals in other cities" links on this page for the full India list.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including JCI, NABH, NABL — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Yes. Share your medical reports with the GAF Healthcare team over WhatsApp or email, and our medical team will review them and come back with a recommended hospital, a treatment plan and an itemised cost estimate before you commit to anything.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for ovarian cancer treatment?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
The figures shown are an indicative planning estimate, not a final quote from a specific hospital. Our team provides a single, itemised, all-inclusive quote before you make any commitment.
🤔

Still have questions?

Our coordinators are here to answer your questions about ovarian cancer treatment in Chennai, India.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for ovarian cancer treatment in Chennai, India.

Contact us to report an inaccuracy on this page.

WhatsApp Us